Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors (Q33944191)
scientific article
Language:
Current Data About Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors
(P31) (Q13442814)
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P304) 473-481
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P478) 18
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P577) Friday, January 1, 1999
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P921) (Q111140)

(Q79460)
(P887)

(Q422248)
(P887)

(P1433) (Q2647982)
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P1476) "Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors" (language: en)
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P2093) Schlaeppi JM
(P1545) 1
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

Wood JM
(P1545) 2
(P248)
(P698) 10855790
(P813) Sunday, July 30, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1023/A:1006358220123
(P698) 10855790
(P6179) 1001021363